• West Pharmaceutical VP, Chief Accounting Officer Chad Winters sold 896 shares on April 27 at USD 300.67.
• Transaction followed exercise of stock options for 896 shares at USD 173.22.
• Winters held 1,522 shares after transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. West Pharmaceutical Services Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000105770-26-000053), on April 29, 2026, and is solely responsible for the information contained therein.